Morgan Stanley: Maintains "Overweight" rating on KINGDEE INT'L (00268), target price HK$11.4
Morgan Stanley believes that LingeeOS is a strategic extension of Kingdee's ERP business, differentiating it from standalone AI agents through proprietary enterprise context, deep workflow integration, and established customer relationships.
Morgan Stanley released a research report stating it is bullish on KINGDEE INT'L (00268) leveraging LingeeOS to expand the depth and ecosystem of enterprise AI. The bank maintains an "Overweight" rating with a target price of HK$11.4.
Morgan Stanley noted that KINGDEE INT'L is expanding the depth and ecosystem of enterprise AI through LingeeOS. Management provided insights on enterprise AI applications, and there is no longer any debate over whether AI can replace ERP.
The bank believes LingeeOS is a strategic extension of Kingdee's ERP business, differentiated from standalone AI agents by virtue of proprietary enterprise context, deep workflow integration, and established customer relationships; Lingee Manage also extends Kingdee's value proposition from operational software to enterprise decision-making and organizational coordination. Although commercialization remains early-stage, key milestones lie in paid adoption, measurable workflow efficiency gains, and converting AI usage into recurring or value-based revenue.
Related Articles

BAOZUN-W (09991) repurchased approximately 42,100 shares for about US$50,000 on October 23.

HAOHAI BIOTEC (06826) repurchased 35,000 shares for HK$558,900 on October 26.

BofA Securities: China Shenhua Energy (01088) Q3 results below expectations, strong coal and weak power, maintain "Buy" rating with target price of HK$48
BAOZUN-W (09991) repurchased approximately 42,100 shares for about US$50,000 on October 23.

HAOHAI BIOTEC (06826) repurchased 35,000 shares for HK$558,900 on October 26.

BofA Securities: China Shenhua Energy (01088) Q3 results below expectations, strong coal and weak power, maintain "Buy" rating with target price of HK$48






